ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University

Simon BerryCEO and co-founder

simon@colalife.org

ColaLife is a charity registered in the UKCharity number: 1142516

• Small, independent and catalytic• Focus on saving children’s lives• Looking for global impact through

• Innovation• Generating robust evidence• Sharing findings and learning• Influencing healthcare strategies

• No commercial interest

2009

2010

2011

2012

2013

1985What is ColaLife and who am I?

Who, how, when

Positive aspects

Negative aspects

The story so far The role of academia

ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016

The future plans

2 31

Who, how, when

Positive aspects

Negative aspects

The story so far The role of academia

ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016

The future plans

2 31

Diarrhoea

19% of infectious disease deaths

Malaria

15% of infectious disease deaths

AIDS

4%

Source: Liu et al (2015) Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. The Lancet.

1

1

1

1

1

<1%

1

1

Source http://guardian.co.uk

1

1

1

1

1

1

1

Kit Yamoyo

Washing Powder

Eggs

Biscuits

Cola – but not Coca-Cola

Bread

1

1

1

1

45%of children in trial areas received ORS/Zinc.

1

Dec-11

Dec-15

Dec-13

Dec-12

Dec-14

Set-up

Trial

Transition

Scale-up

The ColaLife timeline 1

Aug-12

Sep-13

The COTZ trialResearch Design & Methodology

Quasi-experimental, pre-test, post test designBaseline, midline and endline surveys

Target groups: Care-givers of under-5 children and private community retailers

Four Districts – two intervention districts and two comparator districts

Sample sizes:625 HH per district40 retailers per district

impact Mothers in underserved rural communities increase use of ORS and Zinc in home treatment of diarrhoea

purposeTarget communities in two under-served rural districts have improved access to ORS and Zinc

outputs

Profit-driven supply chains improve availability of ADKs (anti-diarrhoea kits) in targeted communities in two underserved rural districts

Mothers/care-givers demonstrate awareness of ADKs and the benefits of the contents (ORS, Zinc and Soap)

access = ADK in the hand of an aware mother/care-giver

Availability = ADK in stock in retail outlets at community level

Generating robust evidence - the COTZ results framework

60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.

0Nobody sold ORS or Zinc in the private sector.

Stock-outs in the public sector were common.

<1%of children received the correct treatment for diarrhoea

7.3kmWas the average distance to ORS.

60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.

0Nobody sold ORS or Zinc in the private sector.

Stock-outs in the public sector were common.

<1%of children received the correct treatment for diarrhoea

7.3kmWas the average distance to ORS.

>26kkits sold into the two remote rural trial areas in 12 months.

60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.

0Nobody sold ORS or Zinc in the private sector.

Stock-outs in the public sector were common.

<1%of children received the correct treatment for diarrhoea

7.3kmWas the average distance to ORS.

>26kkits sold into the two remote rural trial areas in 12 months.

45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.

60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.

0Nobody sold ORS or Zinc in the private sector.

Stock-outs in the public sector were common.

<1%of children received the correct treatment for diarrhoea

7.3kmWas the average distance to ORS.

>26kkits sold into the two remote rural trial areas in 12 months.

45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.

2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.

60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.

0Nobody sold ORS or Zinc in the private sector.

Stock-outs in the public sector were common.

<1%of children received the correct treatment for diarrhoea

7.3kmWas the average distance to ORS.

>26kkits sold into the two remote rural trial areas in 12 months.

45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.

2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.

93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.

60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.

0Nobody sold ORS or Zinc in the private sector.

Stock-outs in the public sector were common.

<1%of children received the correct treatment for diarrhoea

7.3kmWas the average distance to ORS.

>26kkits sold into the two remote rural trial areas in 12 months.

45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.

2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.

93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.

Dec-11

Dec-15

Dec-13

Dec-12

Dec-14

Set-up

Trial

Transition

Scale-up

The ColaLife timeline 1

Feb-15

1

1

1

1

1

1

1

Who, how, when

Positive aspects

Negative aspects

The story so far The role of academia

ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016

The future plans

2 31

Harry Truman once said that “actions are the seeds of fate”. I hope you will consider thise-mail to be one of those seeds.

2

Who, how, when

Positive aspects

Negative aspects

The story so far The role of academia

ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016

The future plans

2 31

Positive aspects | Academic rigor and expertise 2

Positive aspects | Credibility 2

Positive aspects | Dissemination channels available 2

Who, how, when

Positive aspects

Negative aspects

The story so far The role of academia

ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016

The future plans

2 31

Negative aspects | Academic timescales

Aug-13 Aug-14 Aug-15 Aug-16

Trial finished

Dissertation defense

Publication on website

2

Negative aspects | Academic timescales

Aug-13 Aug-14 Aug-15 Aug-16

Trial finished

Dissertation defence

Publication on website

Meanwhile…1 child dies every minute from diarrhoea in sub-Saharan Africa

2

Negative aspects | Open source/original research tension

Negative aspects | Narrow focus

Product Innovation and Human-Centered Design for

Global Health Delivery: Improving Effective Use of

Oral Rehydration Salts Through the Introduction of

an Innovative Diarrhea Treatment Kit Impact of Emulating Commercial, Private-Sector Value-Chains on Access to ORS and Zinc for Childhood Diarrhea in Rural Zambia: Evaluation of the ColaLife Trial

Serving the Underserved: A Description of Rural,

Commercial General Stores as Community-Level

Providers of Public Health Commodities in Zambia

2

Who, how, when

Positive aspects

Negative aspects

The story so far The role of academia

ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016

The future plans

2 31

Future plans and ideas| Complementary dissemination

3

Future plans and ideas| Open source the trial data3

Questions

• Is the open data idea of any interest?• Is there any precedent for this?

• Would academics engage?• Would students engage?• How should we best promote this?• How do we engage Zambian academics?• How could we best support this?

3

Isenberg Family Charitable Foundation

The ColaLife funders past and present – thank you